Yes, statins can lower the risk of death in patients with COVID-19, who also have a history of cardiovascular disease (CVD) and hypertension. If you have these conditions and have one of the indications the statins are prescribed for, then continuing statins can lower your risk of death from COVID-19.
by MM Sperry 2024 Cited by 2others have shown that COVID-19 patients taking drugs from one of the most prescribed drug association between statin treatment and COVID-19
Most are treated with statins, but the impact of these drugs on clinical outcomes of COVID-19 remains unclear. This report is therefore based on meta-analyses of retrospective observational studies aimed at investigating the impact of previous statin therapy in patients hospitalized for COVID-19.
Yes, statins can lower the risk of death in patients with COVID-19, who also have a history of cardiovascular disease (CVD) and hypertension. If you have these conditions and have one of the indications the statins are prescribed for, then continuing statins can lower your risk of death from COVID-19.
Statins and COVID-19: the results form the clinical studies. The effect of statin use on the severity and prognosis of COVID-19 has been the subject of several meta-analyses (Tab. (Tab.2.). 2.). A study by Lee et al. involving 10,448 COVID-19 patients investigated the effect of statin administration on COVID-19 mortality. Moreover, the effect
Since the onset of the COVID-19 pandemic, numerous endeavors were carried out to identify pre-existing drugs that could be swiftly and effectively repurposed to mitigate the morbidity and mortality associated with COVID-19. Among these efforts, statins emerged as the one of the most prominent drugs. 10 Statins have predominant anti
Statin use did not improve the composite poor outcomes of COVID-19. Patients with dyslipidemia should continue taking statin drugs despite COVID-19 infection status, given its beneficial effects on cardiovascular outcomes.
Statin Drugs Laid the Groundwork for COVID-19 HEALTH
Computational tools, medical record analysis, and in vitro experiments reveal that statin drugs differ in their ability to increase survival of COVID-19
Comments